Image
Kathy Jean Schultz
Freelance writer
Freelance writer
The speed of discovery in medical innovation exceeds that of any time in history, and “organoids” created from stem cells are a powerful example.
One woman’s wrong diagnosis spotlights the severity of health threats.
The U.S. Food and Drug Administration will hold hearings about stem cell research this month, on Sept. 12-13. In coming months the agency will review ongoing experimental surgeries that the National Institutes of Health has been monitoring.
Should stem stells be regulated as drugs? The FDA will hold hearings this year to explore stem cell treatments it deems unproven.